5 analysts have expressed a variety of opinions on Vir Biotechnology (NASDAQ:VIR) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent ...
Across the recent three months, 5 analysts have shared their insights on Vir Biotechnology (NASDAQ:VIR), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2025, on November 5, 2025 ...
Hello, and welcome to Vir Biotechnology's Third Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded. [Operator Instructions] I will now turn ...
Hosted on MSN
Evercore ISI Group Initiates Coverage of Vir Biotechnology (VIR) with Outperform Recommendation
Fintel reports that on September 3, 2025, Evercore ISI Group initiated coverage of Vir Biotechnology (NasdaqGS:VIR) with a Outperform recommendation. Analyst Price Forecast Suggests 259.55% Upside As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results